<?xml version="1.0"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Korean J Radiol</journal-id><journal-id journal-id-type="iso-abbrev">Korean J Radiol</journal-id><journal-id journal-id-type="publisher-id">KJR</journal-id><journal-title-group><journal-title>Korean Journal of Radiology</journal-title></journal-title-group><issn pub-type="ppub">1229-6929</issn><issn pub-type="epub">2005-8330</issn><publisher><publisher-name>The Korean Society of Radiology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29520191</article-id><article-id pub-id-type="pmc">5840062</article-id><article-id pub-id-type="doi">10.3348/kjr.2018.19.2.328</article-id><article-categories><subj-group subj-group-type="heading"><subject>Neuroimaging and Head &amp; Neck</subject><subj-group subj-group-type="subheading"><subject>Original Article</subject></subj-group></subj-group></article-categories><title-group><article-title>Early Changes in Apparent Diffusion Coefficient for Salivary Glands during Radiotherapy for Nasopharyngeal Carcinoma Associated with Xerostomia</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Qing</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="A1-kjr-19-328">1</xref><xref ref-type="aff" rid="A2-kjr-19-328">2</xref><xref ref-type="author-notes" rid="FN1-kjr-19-328">*</xref></contrib><contrib contrib-type="author"><name><surname>Wei</surname><given-names>Yu-Mei</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="A3-kjr-19-328">3</xref><xref ref-type="author-notes" rid="FN1-kjr-19-328">*</xref></contrib><contrib contrib-type="author"><name><surname>Qi</surname><given-names>Yuan-Gang</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="A4-kjr-19-328">4</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Li</surname><given-names>Bao-Sheng</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="A5-kjr-19-328">5</xref></contrib></contrib-group><aff id="A1-kjr-19-328"><label>1</label>Department of Radiology, Affiliated Hospital of Shandong Academy of Medical Sciences, Jinan 250031, China.</aff><aff id="A2-kjr-19-328"><label>2</label>Postdoctoral Mobile Station, Tianjin Medical University, Tianjin 300070, China.</aff><aff id="A3-kjr-19-328"><label>3</label>Department of Head and Neck Radiotherapy, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250022, China.</aff><aff id="A4-kjr-19-328"><label>4</label>Department of Radiology, Shandong Cancer Hospital Affiliated to Shandong University, Shandong Academy of Medical Sciences, Jinan 250017, China.</aff><aff id="A5-kjr-19-328"><label>5</label>Department of Radiation Oncology, Shandong Cancer Hospital Affiliated to Shandong University, Shandong Academy of Medical Sciences, Jinan 250017, China.</aff><author-notes><corresp>
Corresponding author: Bao-Sheng Li, MD, Department of Radiation Oncology, Shandong Cancer Hospital Affiliated to Shandong University, Shandong Academy of Medical Sciences, 440# Jiyan Road, Jinan 250017, China. Tel: 86053167626162, Fax: 86053167626162, <email>baoshli1963@163.com</email></corresp><fn id="FN1-kjr-19-328" fn-type="equal"><p><sup>*</sup>These authours contributed equally to this work.</p></fn></author-notes><pub-date pub-type="ppub"><season>Mar-Apr</season><year>2018</year></pub-date><pub-date pub-type="epub"><day>22</day><month>2</month><year>2018</year></pub-date><volume>19</volume><issue>2</issue><fpage>328</fpage><lpage>333</lpage><history><date date-type="received"><day>02</day><month>11</month><year>2016</year></date><date date-type="accepted"><day>02</day><month>8</month><year>2017</year></date></history><permissions><copyright-statement>Copyright &#xA9; 2018 The Korean Society of Radiology</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>The Korean Society of Radiology</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Objective</title><p>To evaluate the early changes in the apparent diffusion coefficient (ADC) of the salivary glands during radiotherapy (RT) and their association with the degree of xerostomia at 6 months after RT in patients with nasopharyngeal carcinoma (NPC).</p></sec><sec><title>Materials and Methods</title><p>We enrolled 26 patients with NPC who underwent RT. Each patient underwent diffusion-weighted MRI of the salivary glands at rest and with gustatory stimulation within 1 week before RT and 2 weeks after the beginning of RT. The ADC at rest (ADC<sub>R</sub>) and increase and increase rate with stimulation (ADC<sub>I</sub>, ADC<sub>IR</sub>) of the submandibular and parotid glands were calculated. The differences in the variables' values between 2 weeks after the beginning of RT and baseline (&#x394;ADC<sub>R</sub>, &#x394;ADC<sub>I</sub>, and &#x394;ADC<sub>IR</sub>) were compared to the degree of xerostomia at 6 months after RT.</p></sec><sec><title>Results</title><p>The ADC<sub>R</sub> of the submandibular and parotid glands were both significantly higher at 2 weeks after the beginning of RT than found at baseline (both <italic>p</italic> &lt; 0.01). The ADC<sub>I</sub> and ADC<sub>IR</sub> for the parotid glands were both significantly lower at 2 weeks after the beginning of RT than found at baseline (both <italic>p</italic> &lt; 0.01). &#x394;ADC<sub>I</sub> and &#x394;ADC<sub>IR</sub> of the parotid glands were associated with the degree of xerostomia at 6 months after RT (<italic>r</italic> = &#x2212;0.61 and &#x2212;0.72, both <italic>p</italic> &lt; 0.01).</p></sec><sec><title>Conclusion</title><p>The ADCs of the salivary glands change early during RT. The differences in the ADC increase and increase rate of the parotid glands between 2 weeks after the beginning of RT and baseline were associated with the degree of xerostomia at 6 months after RT.</p></sec></abstract><kwd-group><kwd>Diffusion-weighted imaging</kwd><kwd>MR imaging</kwd><kwd>Parotid gland</kwd><kwd>Dry mouth</kwd><kwd>Nasopharyngeal carcinoma</kwd><kwd>Head and neck</kwd><kwd>Radiation-induced complication</kwd><kwd>Quality of life</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution>Shandong Province</institution><institution-id institution-id-type="CrossRef">http://dx.doi.org/10.13039/501100003091</institution-id></institution-wrap></funding-source><award-id>2015WS0158</award-id></award-group></funding-group></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>Xerostomia is a common radiation-induced complication in patients with nasopharyngeal carcinoma (NPC) after a radical course of radiotherapy (RT) (<xref rid="B1-kjr-19-328" ref-type="bibr">1</xref><xref rid="B2-kjr-19-328" ref-type="bibr">2</xref>). Persistent xerostomia, due to damage to the salivary glands, causes difficulties in mastication and swallowing and enhances the risk of dental problems, subsequently degrading the quality of life in long-term survivors; however, we have no effective control methods (<xref rid="B3-kjr-19-328" ref-type="bibr">3</xref><xref rid="B4-kjr-19-328" ref-type="bibr">4</xref>). The early detection and prevention of xerostomia would be of great value in practice.</p><p>The development of xerostomia likely depends on various prognostic factors: radiation dose distribution, demographics, and tumor and treatment-related factors (<xref rid="B5-kjr-19-328" ref-type="bibr">5</xref>). Many studies aimed at improving the predictive models for baseline subjective scores and patient-dependent risks, but the results were discrepant (<xref rid="B6-kjr-19-328" ref-type="bibr">6</xref><xref rid="B7-kjr-19-328" ref-type="bibr">7</xref>). The mechanism of radiation-induced xerostomia might be complicated. Building a predictive model that summarizes all factors would be difficult.</p><p>A diffusion-weighted MRI (DWI) is commonly performed in patients with head and neck diseases (<xref rid="B8-kjr-19-328" ref-type="bibr">8</xref>). The parameters of the apparent diffusion coefficient (ADC) can reflect the microstructures or pathophysiologic conditions of tissues, even during the early stages of the disease (<xref rid="B9-kjr-19-328" ref-type="bibr">9</xref>). Some studies found that the ADC of the parotid glands changed (i.e., increased or decreased in different studies) after gustatory stimulation compared to the baseline ADC (<xref rid="B10-kjr-19-328" ref-type="bibr">10</xref><xref rid="B11-kjr-19-328" ref-type="bibr">11</xref>). Several studies investigated the diffusional alternations in the salivary glands after RT (<xref rid="B11-kjr-19-328" ref-type="bibr">11</xref><xref rid="B12-kjr-19-328" ref-type="bibr">12</xref>). Although these findings differed from each other, the ADC values certainly could reflect the function of the salivary glands and the grade of xerostomia after RT in some ways. To the best of our knowledge, the early changes in the ADC of the salivary glands during RT and their association with xerostomia after RT has not been documented. In this study, we sought to evaluate the early changes in the ADC (2 weeks after the beginning of RT) of the salivary glands and their association with the xerostomia degree at 6 months after RT.</p></sec><sec sec-type="materials|methods"><title>MATERIALS AND METHODS</title><sec><title>Patients</title><p>From June 2014 to December 2015, 26 consecutive patients with NPC who were only undergoing intensity-modulated RT (IMRT) were enrolled in another project where the changes over time in the ADC of the salivary glands during RT was observed. None of the patients had a history of salivary gland disease prior to RT. No patient received any treatment for related clinical symptoms of xerostomia during or after RT. Here, we retrospectively analyzed these data to investigate any relationships to the degree of xerostomia at 6 months after RT. The Institutional Ethics Committee approved the study. An informed consent form was signed by each patient before enrollment.</p></sec><sec><title>Radiotherapy</title><p>All patients were fixed with a thermoplastic mask. The simulation CT images (slice thickness 3 mm) ranged from the vertex cranii to 5 cm below the clavicular heads. All patients received IMRT with a simultaneous integrated boost. The gross tumor volume (GTV) included the primary NPC and lymph node-involved tumors exhibited by contrast-enhanced imaging. Clinical target volume 1 (CTV 1), as the high-risk region, was outlined by adding a 5-mm margin to GTV, which contained the inferior sphenoid sinus, clivus, basis cranii, nasopharynx, ipsilateral parapharyngeal space, posterior third of the nasal cavity, maxillary sinuses, and level II, III, and Va lymph nodes. CTV 2, as the low-risk region, included the lower neck under the cricothyroid membrane. A 3 mm margin was also suitable in regions close to the brainstem, optic nerves, and optic chiasm. All CTVs were outlined according to the Radiation Therapy Oncology Group's (RTOG) recommendations (<xref rid="B13-kjr-19-328" ref-type="bibr">13</xref>). The planning target volume (PTV) was bounded by appending a 5 mm margin to the CTV in all directions.</p><p>The prescribed RT dose was 66 Gy/30 fractions, 60 Gy/30 fractions, and 54 Gy/30 fractions to the planning gross tumor volume, PTV 1 and PTV 2, respectively, at 5 fractions per week. After a course of RT, the total dose was 36.45 &#xB1; 5.62 Gy (mean &#xB1; standard deviation; range 25.21&#x2013;48.83 Gy) to the parotid glands and 55.71 &#xB1; 5.13 Gy (range 49.35&#x2013;69.22 Gy) to the submandibular glands.</p></sec><sec><title>Imaging Protocol</title><p>Each patient underwent MRI within one week prior to RT and two weeks after the beginning of RT. All patients were asked to fast for at least 4 hours before the examination. All MRI examinations involved a 3T MR system (Achieva 3.0T; Philips Healthcare, Eindhoven, The Netherlands). The patients were imaged supine with a 16-channel head-neck array coil. An Axial and sagittal T1-weighted spin-echo sequence (repetition time [TR] 400 ms, echo time [TE] 10.5 ms, slice thickness 4 mm, slice interval 1 mm, field of view [FOV] 22 &#xD7; 22 cm, matrix 136 &#xD7; 109) and fast spin-echo T2-weighted images were obtained first as routine procedure. The T2-weighted sequence (TR 5563 ms, TE 46 ms, slice thickness 4 mm, slice interval 1 mm, FOV 22 &#xD7; 22 cm, matrix 136 &#xD7; 109) was used as a reference for the following DWI examinations to improve the outlining of the salivary glands. The images ranged from the basis cranii to the undersurface of the submandibular glands and contained the whole volume of the salivary glands.</p><p>An axial spin-echo echo-planar DWI sequence was then conducted (TR 5563 ms, TE 46 ms, matrix 136 &#xD7; 109, b-values 0, 200, 500, 800 s/mm<sup>2</sup>, number of signal averages 2, scan time 87 seconds); the imaging FOV, slice thickness, and interval were equal to those used in the T2-weighted imaging. After a DWI sequence obtained at rest, six 100-mg tablets of ascorbic acid were placed in the patients' mouths. The patients were asked not to chew them. Immediately after, the DWI was repeated 10 times with 13-second intervals between the contiguous sequences.</p></sec><sec><title>Data Acquisition And Analysis</title><p>The ADC maps for all DWI images were constructed and transferred automatically to a workstation (Extended MR Workspace 2.6.3.4; Philips Healthcare). Three adjacent sections containing the biggest volumes of each salivary gland were used for analysis. In the T2-weighted images, the region of interest (ROI) on each section was outlined by hand such that it contained as much of the gland parenchyma as possible. These ROIs were copied to the matching ADC maps automatically for ADC calculations (<xref ref-type="fig" rid="F1-kjr-19-328">Fig. 1</xref>).</p><p>The ADC values at rest (ADC<sub>R</sub>) and increase and increase rate with stimulation (ADC<sub>I</sub>, ADC<sub>IR</sub>) for the bilateral submandibular and parotid glands were calculated. The ADC<sub>I</sub> was defined as the ADC difference between the peak value during stimulation and the baseline value at rest. The ADC<sub>IR</sub> was defined as the ratio of ADC<sub>I</sub> to the baseline value at rest. The differences in the absolute values of these variables between 2 weeks after the beginning of RT and baseline (&#x394;ADC<sub>R</sub>, &#x394;ADC<sub>I</sub>, and &#x394;ADC<sub>IR</sub>) were compared with the degree of xerostomia at 6 months after RT. The clinical degree of xerostomia before and at 6 months after RT was assessed according to the morbidity scoring system developed by the RTOG/European Organization for Research and Treatment of Cancer (EORTC) (<xref rid="B14-kjr-19-328" ref-type="bibr">14</xref>).</p></sec><sec><title>Statistical Analysis</title><p>All data were presented as a percentage (%) or median (interquartile range). A Wilcoxon paired test was used to compare the ADC values of the salivary glands at rest and during stimulation as well as before and 2 weeks after the beginning of RT. Spearman's Rank-Order Correlations were used to test the associations between gender, age, &#x394;ADC<sub>R</sub>, &#x394;ADC<sub>I</sub>, &#x394;ADC<sub>IR</sub>, and RT dose of the parotid and submandibular glands and the degree of xerostomia at 6 months after RT. The level of statistical significance was set at <italic>p</italic> &lt; 0.05. Statistical analyses involved the use of the SPSS 18.0 software (SPSS Inc., Chicago, IL, USA).</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>For the 26 patients (17 men; mean age, 51 years [range 37&#x2013;63]), at rest, the ADC<sub>R</sub> (&#xD7; 10<sup>&#x2212;3</sup> mm<sup>2</sup>/s) of the parotid and submandibular glands were both significantly higher at 2 weeks after the beginning of RT than it was before RT (1.35 [1.20&#x2013;1.52] vs. 0.94 [0.88&#x2013;0.96], <italic>p</italic> &lt; 0.01; 1.57 [1.47&#x2013;1.69] vs. 1.24 [1.18&#x2013;1.29], <italic>p</italic> &lt; 0.01) (<xref ref-type="fig" rid="F2-kjr-19-328">Fig. 2</xref>). The ADC of the parotid glands increased and then decreased in fluctuation, and the peak value appeared within the first 6 minutes after the beginning of stimulation both before and after RT. The ADC<sub>I</sub> (&#xD7; 10<sup>&#x2212;3</sup> mm<sup>2</sup>/s) and ADC<sub>IR</sub> (%) values for the parotid glands after stimulation were both significantly lower at 2 weeks after the beginning of RT than they were before RT (0.27 [0.21&#x2013;0.33] vs. 0.36 [0.32&#x2013;0.42], <italic>p</italic> &lt; 0.01; 22.17 [16.30&#x2013;25.20] vs. 38.36 [32.92&#x2013;46.79], <italic>p</italic> &lt; 0.01). The ADC for the submandibular glands also increased slightly after stimulation both before and after RT, but the ADC<sub>I</sub> (&#xD7; 10<sup>&#x2212;3</sup> mm<sup>2</sup>/s) and ADC<sub>IR</sub> (%) did not differ significantly (0.13 [0.07&#x2013;0.16] vs. 0.15 [0.10&#x2013;0.19], <italic>p</italic> = 0.19; 12.31 [8.48&#x2013;17.23] vs. 16.24 [11.18&#x2013;18.29], <italic>p</italic> = 0.43).</p><p>Before RT, xerostomia assessed by the RTOG/EORTC morbidity score was grade 0 for all patients. At 6 months after RT, xerostomia varied across patients: grade 0 for 1 patient (3.85%), grade 1 for 12 patients (46.15%), grade 2 for 11 patients (42.30%) and grade 3 for 2 patients (7.70%). The spearman correlation coefficient indicated that &#x394;ADC<sub>I</sub> and &#x394;ADC<sub>IR</sub> of the parotid glands were associated with the degree of xerostomia (<italic>r</italic> = &#x2212;0.61, <italic>p</italic> &lt; 0.01; <italic>r</italic> = &#x2212;0.72, <italic>p</italic> &lt; 0.01). The &#x394;ADC<sub>R</sub> of the parotid glands was also significantly related to xerostomia (<italic>p</italic> = 0.04) but the correlation coefficient was as small as 0.41. At the same time, the &#x394;ADC<sub>R</sub> of the submandibular glands, gender, age and RT dose to the parotid and submandibular glands was not significantly related to the degree of xerostomia at 6 months after RT (<italic>r</italic> = 0.35, 0.21, 0.49, 0.51, and 0.57, respectively, all <italic>p</italic> &gt; 0.05).</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>The DWI of the salivary glands at rest and with gustatory stimulation has been valuable for visualizing the diffusional alterations of the salivary glands before and after RT in patients with NPC (<xref rid="B11-kjr-19-328" ref-type="bibr">11</xref>). We wondered whether the early changes in the ADC of the salivary glands of such patients during RT were associated with xerostomia. Here, we evaluated the association of early changes (2 weeks after the beginning of RT) in the ADC of the salivary glands during RT with the degree of xerostomia at 6 months after RT. Because the parotid gland mainly secretes saliva in stimulated conditions while the submandibular gland mainly works at rest, some studies only investigated the ADC changes of the parotid gland with stimulation (<xref rid="B11-kjr-19-328" ref-type="bibr">11</xref>). In this study, we investigated the ADC changes of the parotid and submandibular glands. Our preliminary results indicated that the mean ADC values for the parotid and submandibular glands at rest were both significantly higher at 2 weeks after the beginning of RT than they were before RT. The ADC increase and increase rate of the parotid glands with stimulation during RT were both significantly lower than they were before RT. The ADC increase and increase rate of the submandibular glands did not alter significantly. We hypothesized that the sensitivity to radiation might be different between the parotid and submandibular glands. The differences in the ADC increase and increase rate of the parotid glands were associated with the degree of xerostomia at 6 months after RT.</p><p>In previous studies, the ADC values of the salivary glands at rest varied greatly. The ADC of the parotid glands varied from 0.28 to 2.42 &#xD7; 10<sup>&#x2212;3</sup> mm<sup>2</sup>/s even in healthy volunteers (<xref rid="B15-kjr-19-328" ref-type="bibr">15</xref><xref rid="B16-kjr-19-328" ref-type="bibr">16</xref>). In the present study, the ADC for the parotid and submandibular glands at rest was 0.94 (0.88&#x2212;0.96) and 1.24 (1.18&#x2212;1.29) &#xD7; 10<sup>&#x2212;3</sup> mm<sup>2</sup>/s. Some authors believed that this discrepancy was likely attributed to the b values used because previous research showed that the ADC of the parotid gland is negatively affected by b values (<xref rid="B10-kjr-19-328" ref-type="bibr">10</xref>). The ADC is affected also by pulse sequences, accelerating factors, histological components, fat saturations, and bulk motions (<xref rid="B17-kjr-19-328" ref-type="bibr">17</xref><xref rid="B18-kjr-19-328" ref-type="bibr">18</xref>). Moreover, some authors insisted that high b values ought to be used when assessing the diffusion of the salivary glands (<xref rid="B11-kjr-19-328" ref-type="bibr">11</xref>) because the ADC values of obtained biological tissues at low b values were thought to reflect the fast water motion of the blood and saliva flows known as perfusion (<xref rid="B10-kjr-19-328" ref-type="bibr">10</xref>); whereas, the high b values were thought to reflect the slow water motion known as diffusion. The contribution of perfusion to the ADC decreases with increasing b values (<xref rid="B19-kjr-19-328" ref-type="bibr">19</xref>). However, Cho et al. (<xref rid="B20-kjr-19-328" ref-type="bibr">20</xref>) found that salivary flow rates were severely reduced in patients who had undergone RT. We used low and high b values in this study to reflect both the perfusion and diffusion changes of the salivary glands after RT. We found increased ADC values for salivary glands during stimulation before RT, and the reaction to stimulation still occurred 2 weeks after the beginning of RT, which is similar to that found in previous studies (<xref rid="B11-kjr-19-328" ref-type="bibr">11</xref><xref rid="B21-kjr-19-328" ref-type="bibr">21</xref>).</p><p>The ADC changes of the salivary glands induced by radiation have been examined by some authors, but the results differed greatly. Zhang et al. (<xref rid="B16-kjr-19-328" ref-type="bibr">16</xref>) first reported reduced parotid ADC after irradiation. However, some later research found significantly increased parotid ADC after RT (<xref rid="B11-kjr-19-328" ref-type="bibr">11</xref><xref rid="B12-kjr-19-328" ref-type="bibr">12</xref><xref rid="B22-kjr-19-328" ref-type="bibr">22</xref>). The b-values were different in these studies. In our study, we found that the ADC of the salivary glands increased after RT. Our results aligned with previous studies. Zhang et al. (<xref rid="B11-kjr-19-328" ref-type="bibr">11</xref>) also found the increase between the maximum and the baseline was greater after RT than that found before RT. They attributed this finding to increased water contents in the damaged parotid glands and delayed emptying of saliva. However, we found that the ADC increase and increase rate of the parotid glands with stimulation were both significantly lower during RT than that found before RT. We performed MRI during instead of after RT. Perhaps the secretion is damaged while the salivary duct system remains normal in the early stages while undergoing RT. Kato et al. (<xref rid="B21-kjr-19-328" ref-type="bibr">21</xref>) found that the mean increase rate was significantly smaller in patients with primary xerostomia than it was for those without it. We supposed that the decrease in ADC increase rate of the parotid glands during RT may have the same mechanism as primary xerostomia. This indicated the response of the salivary glands to stimulation was damaged during RT. Moreover, we found that the differences in the ADC increase and increase rate for the parotid glands between during and before RT were associated with the degree of xerostomia at 6 months after RT.</p><p>The present study had some limitations. First, the follow-up period after RT was insufficient. The degree of xerostomia varied over time after RT (<xref rid="B23-kjr-19-328" ref-type="bibr">23</xref>), and we only investigated ADC variables with xerostomia at 6 months after RT. So the follow-up period should be increased to assess late side effects. Second, we used a different b-value than other studies. Although some authors thought that high b values should be used when evaluating salivary glands after RT (<xref rid="B11-kjr-19-328" ref-type="bibr">11</xref>), we reasoned that perfusion alterations of the salivary glands after RT should not be neglected. The standard DWI protocol has not been established, so comparing these results is difficult. Finally, our sample size was small.</p><p>In this study, we demonstrated the ADC changes of the salivary glands with gustatory stimulation during the early stages while receiving RT. The difference in the ADC increase and increase rate of the parotid glands between 2 weeks after the beginning of RT and baseline was associated with the degree of xerostomia at 6 months after RT. The relationship between the early changes in the ADC of the salivary glands during RT and the degree of xerostomia should be verified by further investigations.</p></sec></body><back><fn-group><fn fn-type="supported-by"><p>This study was supported by the Projects of Medical and Health Technology Development Program in Shandong Province, People's Republic of China (Grant No 2015WS0158).</p></fn></fn-group><ref-list><ref id="B1-kjr-19-328"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agulnik</surname><given-names>M</given-names></name><name><surname>Epstein</surname><given-names>JB</given-names></name></person-group><article-title>Nasopharyngeal carcinoma: current management, future directions and dental implications</article-title><source>Oral Oncol</source><year>2008</year><volume>44</volume><fpage>617</fpage><lpage>627</lpage><pub-id pub-id-type="pmid">18061518</pub-id></element-citation></ref><ref id="B2-kjr-19-328"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Talmi</surname><given-names>YP</given-names></name><name><surname>Horowitz</surname><given-names>Z</given-names></name><name><surname>Bedrin</surname><given-names>L</given-names></name><name><surname>Wolf</surname><given-names>M</given-names></name><name><surname>Chaushu</surname><given-names>G</given-names></name><name><surname>Kronenberg</surname><given-names>J</given-names></name><etal/></person-group><article-title>Quality of life of nasopharyngeal carcinoma patients</article-title><source>Cancer</source><year>2002</year><volume>94</volume><fpage>1012</fpage><lpage>1017</lpage><pub-id pub-id-type="pmid">11920470</pub-id></element-citation></ref><ref id="B3-kjr-19-328"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chambers</surname><given-names>MS</given-names></name><name><surname>Garden</surname><given-names>AS</given-names></name><name><surname>Kies</surname><given-names>MS</given-names></name><name><surname>Martin</surname><given-names>JW</given-names></name></person-group><article-title>Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management</article-title><source>Head Neck</source><year>2004</year><volume>26</volume><fpage>796</fpage><lpage>807</lpage><pub-id pub-id-type="pmid">15350026</pub-id></element-citation></ref><ref id="B4-kjr-19-328"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jellema</surname><given-names>AP</given-names></name><name><surname>Slotman</surname><given-names>BJ</given-names></name><name><surname>Doornaert</surname><given-names>P</given-names></name><name><surname>Leemans</surname><given-names>CR</given-names></name><name><surname>Langendijk</surname><given-names>JA</given-names></name></person-group><article-title>Impact of radiation-induced xerostomia on quality of life after primary radiotherapy among patients with head and neck cancer</article-title><source>Int J Radiat Oncol Biol Phys</source><year>2007</year><volume>69</volume><fpage>751</fpage><lpage>760</lpage><pub-id pub-id-type="pmid">17560735</pub-id></element-citation></ref><ref id="B5-kjr-19-328"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van de Water</surname><given-names>TA</given-names></name><name><surname>Bijl</surname><given-names>HP</given-names></name><name><surname>Westerlaan</surname><given-names>HE</given-names></name><name><surname>Langendijk</surname><given-names>JA</given-names></name></person-group><article-title>Delineation guidelines for organs at risk involved in radiation-induced salivary dysfunction and xerostomia</article-title><source>Radiother Oncol</source><year>2009</year><volume>93</volume><fpage>545</fpage><lpage>552</lpage><pub-id pub-id-type="pmid">19853316</pub-id></element-citation></ref><ref id="B6-kjr-19-328"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gr&#xE9;goire</surname><given-names>V</given-names></name><name><surname>De Neve</surname><given-names>W</given-names></name><name><surname>Eisbruch</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>N</given-names></name><name><surname>Van</surname><given-names>den</given-names></name><name><surname>Van Gestel</surname><given-names>D</given-names></name></person-group><article-title>Intensity-modulated radiation therapy for head and neck carcinoma</article-title><source>Oncologist</source><year>2007</year><volume>12</volume><fpage>555</fpage><lpage>564</lpage><pub-id pub-id-type="pmid">17522243</pub-id></element-citation></ref><ref id="B7-kjr-19-328"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leek</surname><given-names>H</given-names></name><name><surname>Albertsson</surname><given-names>M</given-names></name></person-group><article-title>Pilocarpine treatment of xerostomia in head and neck patients</article-title><source>Micron</source><year>2002</year><volume>33</volume><fpage>153</fpage><lpage>155</lpage><pub-id pub-id-type="pmid">11567884</pub-id></element-citation></ref><ref id="B8-kjr-19-328"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>XQ</given-names></name><name><surname>Choi</surname><given-names>YJ</given-names></name><name><surname>Sung</surname><given-names>YS</given-names></name><name><surname>Yoon</surname><given-names>RG</given-names></name><name><surname>Jang</surname><given-names>SW</given-names></name><name><surname>Park</surname><given-names>JE</given-names></name><etal/></person-group><article-title>Intravoxel incoherent motion MR imaging in the head and neck: correlation with dynamic contrast-enhanced MR imaging and diffusion-weighted imaging</article-title><source>Korean Journal of Radiology</source><year>2016</year><volume>17</volume><fpage>641</fpage><lpage>649</lpage><pub-id pub-id-type="pmid">27587952</pub-id></element-citation></ref><ref id="B9-kjr-19-328"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Takashima</surname><given-names>S</given-names></name><name><surname>Takayama</surname><given-names>F</given-names></name><name><surname>Kawakami</surname><given-names>S</given-names></name><name><surname>Saito</surname><given-names>A</given-names></name><name><surname>Matsushita</surname><given-names>T</given-names></name><etal/></person-group><article-title>Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging</article-title><source>Radiology</source><year>2001</year><volume>220</volume><fpage>621</fpage><lpage>630</lpage><pub-id pub-id-type="pmid">11526259</pub-id></element-citation></ref><ref id="B10-kjr-19-328"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thoeny</surname><given-names>HC</given-names></name><name><surname>De Keyzer</surname><given-names>F</given-names></name><name><surname>Boesch</surname><given-names>C</given-names></name><name><surname>Hermans</surname><given-names>R</given-names></name></person-group><article-title>Diffusion-weighted imaging of the parotid gland: influence of the choice of b-values on the apparent diffusion coefficient value</article-title><source>J Magn Reson Imaging</source><year>2004</year><volume>20</volume><fpage>786</fpage><lpage>790</lpage><pub-id pub-id-type="pmid">15503336</pub-id></element-citation></ref><ref id="B11-kjr-19-328"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Ou</surname><given-names>D</given-names></name><name><surname>Gu</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>X</given-names></name><name><surname>Peng</surname><given-names>W</given-names></name><name><surname>Mao</surname><given-names>J</given-names></name><etal/></person-group><article-title>Diffusion-weighted MR imaging of salivary glands with gustatory stimulation: comparison before and after radiotherapy</article-title><source>Acta Radiol</source><year>2013</year><volume>54</volume><fpage>928</fpage><lpage>933</lpage><pub-id pub-id-type="pmid">23821773</pub-id></element-citation></ref><ref id="B12-kjr-19-328"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dirix</surname><given-names>P</given-names></name><name><surname>De Keyzer</surname><given-names>F</given-names></name><name><surname>Vandecaveye</surname><given-names>V</given-names></name><name><surname>Stroobants</surname><given-names>S</given-names></name><name><surname>Hermans</surname><given-names>R</given-names></name><name><surname>Nuyts</surname><given-names>S</given-names></name></person-group><article-title>Diffusion-weighted magnetic resonance imaging to evaluate major salivary gland function before and after radiotherapy</article-title><source>Int J Radiat Oncol Biol Phys</source><year>2008</year><volume>71</volume><fpage>1365</fpage><lpage>1371</lpage><pub-id pub-id-type="pmid">18355977</pub-id></element-citation></ref><ref id="B13-kjr-19-328"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>N</given-names></name><name><surname>Harris</surname><given-names>J</given-names></name><name><surname>Garden</surname><given-names>AS</given-names></name><name><surname>Straube</surname><given-names>W</given-names></name><name><surname>Glisson</surname><given-names>B</given-names></name><name><surname>Xia</surname><given-names>P</given-names></name><etal/></person-group><article-title>Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225</article-title><source>J Clin Oncol</source><year>2009</year><volume>27</volume><fpage>3684</fpage><lpage>3690</lpage><pub-id pub-id-type="pmid">19564532</pub-id></element-citation></ref><ref id="B14-kjr-19-328"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>JD</given-names></name><name><surname>Stetz</surname><given-names>J</given-names></name><name><surname>Pajak</surname><given-names>TF</given-names></name></person-group><article-title>Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)</article-title><source>Int J Radiat Oncol Biol Phys</source><year>1995</year><volume>31</volume><fpage>1341</fpage><lpage>1346</lpage><pub-id pub-id-type="pmid">7713792</pub-id></element-citation></ref><ref id="B15-kjr-19-328"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sumi</surname><given-names>M</given-names></name><name><surname>Takagi</surname><given-names>Y</given-names></name><name><surname>Uetani</surname><given-names>M</given-names></name><name><surname>Morikawa</surname><given-names>M</given-names></name><name><surname>Hayashi</surname><given-names>K</given-names></name><name><surname>Kabasawa</surname><given-names>H</given-names></name><etal/></person-group><article-title>Diffusion-weighted echoplanar MR imaging of the salivary glands</article-title><source>AJR Am J Roentgenol</source><year>2002</year><volume>178</volume><fpage>959</fpage><lpage>965</lpage><pub-id pub-id-type="pmid">11906883</pub-id></element-citation></ref><ref id="B16-kjr-19-328"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Murata</surname><given-names>Y</given-names></name><name><surname>Ishida</surname><given-names>R</given-names></name><name><surname>Ohashi</surname><given-names>I</given-names></name><name><surname>Yoshimura</surname><given-names>R</given-names></name><name><surname>Shibuya</surname><given-names>H</given-names></name></person-group><article-title>Functional evaluation with intravoxel incoherent motion echo-planar MRI in irradiated salivary glands: a correlative study with salivary gland scintigraphy</article-title><source>J Magn Reson Imaging</source><year>2001</year><volume>14</volume><fpage>223</fpage><lpage>229</lpage><pub-id pub-id-type="pmid">11536398</pub-id></element-citation></ref><ref id="B17-kjr-19-328"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>HC</given-names></name><name><surname>Juan</surname><given-names>CJ</given-names></name><name><surname>Chiu</surname><given-names>HC</given-names></name><name><surname>Cheng</surname><given-names>CC</given-names></name><name><surname>Chiu</surname><given-names>SC</given-names></name><name><surname>Liu</surname><given-names>YJ</given-names></name><etal/></person-group><article-title>Effects of gender, age, and body mass index on fat contents and apparent diffusion coefficients in healthy parotid glands: an MRI evaluation</article-title><source>Eur Radiol</source><year>2014</year><volume>24</volume><fpage>2069</fpage><lpage>2076</lpage><pub-id pub-id-type="pmid">24972952</pub-id></element-citation></ref><ref id="B18-kjr-19-328"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>YJ</given-names></name><name><surname>Lee</surname><given-names>YH</given-names></name><name><surname>Chang</surname><given-names>HC</given-names></name><name><surname>Huang</surname><given-names>TY</given-names></name><name><surname>Chiu</surname><given-names>HC</given-names></name><name><surname>Wang</surname><given-names>CW</given-names></name><etal/></person-group><article-title>A potential risk of overestimating apparent diffusion coefficient in parotid glands</article-title><source>PLoS One</source><year>2015</year><volume>10</volume><elocation-id>e0124118</elocation-id><pub-id pub-id-type="pmid">25922948</pub-id></element-citation></ref><ref id="B19-kjr-19-328"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Bihan</surname><given-names>D</given-names></name><name><surname>Breton</surname><given-names>E</given-names></name><name><surname>Lallemand</surname><given-names>D</given-names></name><name><surname>Aubin</surname><given-names>ML</given-names></name><name><surname>Vignaud</surname><given-names>J</given-names></name><name><surname>Laval-Jeantet</surname><given-names>M</given-names></name></person-group><article-title>Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging</article-title><source>Radiology</source><year>1988</year><volume>168</volume><fpage>497</fpage><lpage>505</lpage><pub-id pub-id-type="pmid">3393671</pub-id></element-citation></ref><ref id="B20-kjr-19-328"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>MA</given-names></name><name><surname>Ko</surname><given-names>JY</given-names></name><name><surname>Kim</surname><given-names>YK</given-names></name><name><surname>Kho</surname><given-names>HS</given-names></name></person-group><article-title>Salivary flow rate and clinical characteristics of patients with xerostomia according to its aetiology</article-title><source>J Oral Rehabil</source><year>2010</year><volume>37</volume><fpage>185</fpage><lpage>193</lpage><pub-id pub-id-type="pmid">20002531</pub-id></element-citation></ref><ref id="B21-kjr-19-328"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>H</given-names></name><name><surname>Kanematsu</surname><given-names>M</given-names></name><name><surname>Toida</surname><given-names>M</given-names></name><name><surname>Kawaguchi</surname><given-names>T</given-names></name><name><surname>Shibata</surname><given-names>T</given-names></name><name><surname>Kajita</surname><given-names>K</given-names></name><etal/></person-group><article-title>Salivary gland function evaluated by diffusion-weighted MR imaging with gustatory stimulation: preliminary results</article-title><source>J Magn Reson Imaging</source><year>2011</year><volume>34</volume><fpage>904</fpage><lpage>909</lpage><pub-id pub-id-type="pmid">21837780</pub-id></element-citation></ref><ref id="B22-kjr-19-328"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Studer</surname><given-names>G</given-names></name><name><surname>Kirilova</surname><given-names>A</given-names></name><name><surname>Jaffray</surname><given-names>D</given-names></name><name><surname>Dawson</surname><given-names>L</given-names></name><name><surname>Lockwood</surname><given-names>G</given-names></name><name><surname>Bayley</surname><given-names>A</given-names></name><etal/></person-group><article-title>Major salivary gland function: diffusion-weighted MRI (DWI) assessment before, during and after radiation therapy</article-title><source>Int J Radiat Oncol Biol Phys</source><year>2005</year><volume>63</volume><fpage>S361</fpage></element-citation></ref><ref id="B23-kjr-19-328"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>A</given-names></name><name><surname>Kim</surname><given-names>HM</given-names></name><name><surname>Terrell</surname><given-names>JE</given-names></name><name><surname>Dawson</surname><given-names>LA</given-names></name><name><surname>Ship</surname><given-names>JA</given-names></name><name><surname>Eisbruch</surname><given-names>A</given-names></name></person-group><article-title>Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study</article-title><source>Int J Radiat Oncol Biol Phys</source><year>2003</year><volume>57</volume><fpage>61</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">12909216</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1-kjr-19-328" orientation="portrait" position="float"><label>Fig. 1</label><caption><title>Measurement of ADC of salivary glands.</title><p>T2WI image <bold>(A)</bold> and corresponding ADC map <bold>(B)</bold> for 60-year-old male patient with nasopharyngeal carcinoma before radiotherapy. After placing ROI in manner that enclosed as much of gland parenchyma as possible in reference to T2WI, ROI was automatically copied to corresponding ADC map for further analysis. ADC = apparent diffusion coefficient, ROI = region of interest, T2WI = T2-weighted imaging</p></caption><graphic xlink:href="kjr-19-328-g001"/></fig><fig id="F2-kjr-19-328" orientation="portrait" position="float"><label>Fig. 2</label><caption><title>ADC maps of parotid glands of 53-year-old male patient with nasopharyngeal carcinoma before (A) and during (B) RT.</title><p>Mean ADC of parotid glands at rest was 0.89 &#xD7; 10<sup>&#x2212;3</sup> mm<sup>2</sup>/s before RT and increased to 1.24 &#xD7; 10<sup>&#x2212;3</sup> mm<sup>2</sup>/s during RT. RT = radiotherapy</p></caption><graphic xlink:href="kjr-19-328-g002"/></fig></floats-group></article>
